Both in Biotechnology
Relay Therapeutics vs Adaptive Biotechnologies
Over the past year RLAY returned +162.8% and ADPT returned +57.9%; their daily moves had a correlation of 0.25.
RLAY +162.8% ADPT +57.9%Growth of $1, one year, split-adjusted
| Metric | RLAY | ADPT |
|---|---|---|
| Price | $18.03 | $26.71 |
| Market cap | $3.95B | $4.26B |
| Today | +3.38% | +3.53% |
| 1 month | −3.8% | −0.7% |
| 6 months | +39.6% | +85.1% |
| Year to date | +113.1% | +64.5% |
| 1 year | +159.8% | +54.0% |
| Revenue growth (YoY) | −48.3% | +21.5% |
| Gross margin | 100.0% | 71.8% |
| Net margin | −23916.3% | −55.6% |
| P/E (TTM) | — | — |
| Price / sales | 381.8× | 13.8× |
| Net cash | $910.9M | $9.4M |
| Dividend yield | — | — |
| Volatility (60d) | 49.2% | 51.6% |
| Short % of float | 27.9% | 10.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).